"For over two decades, CIT has been dedicated to assisting pharmaceutical companies find new cures to help patients better manage their healthcare."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Otsuka Pharmaceutical Development & Commercialization, Inc.
4
Hoffmann-La Roche
3
Forest Laboratories
2
Karuna Therapeutics
2
Takeda
2
AbbVie
1
Allergan
1
Assurex Health Inc.
1
BlackThorn Therapeutics, Inc.
1
Boehringer Ingelheim
1
Cerecin
1
Clinical Trials at CITrials
During the past decade, CITrials conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 9 clinical trials were completed, i.e. on
average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
2015-07-21
2019-02-27
Completed
3,021
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CITrials" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials, followed by "Hoffmann-La Roche" with 3 trials
sponsored, "Forest Laboratories" with 2 trials sponsored, "Karuna Therapeutics" with 2 trials sponsored and "Takeda"
with 2 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CITrials"
#1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Neumora Therapeutics, Inc." with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at CITrials
According to Clinical.Site data, the most researched conditions in "CITrials" are
"Schizophrenia" (8 trials), "Alzheimer's Disease" (4 trials), "Bipolar I Disorder" (3 trials), "Major Depressive Disorder" (3 trials) and "Schizophrenia, Schizoaffective Disorder" (2 trials). Many other conditions were trialed in "CITrials" in a lesser frequency.
Clinical Trials Intervention Types at CITrials
Most popular intervention types in "CITrials" are "Drug" (23 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Brexpiprazole" (2 trials), "RO6889450" (2 trials), "TAK-994" (2 trials) and "Vilazodone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CITrials
The vast majority of trials in "CITrials" are
24 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CITrials
Currently, there are NaN active trials in "CITrials".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in CITrials,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in CITrials, 1 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".